Clinical trial
RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose…
NCT00485342 · Hospices Civils de Lyon, Other · Unknown status
Key facts
| NCT number | NCT00485342 |
|---|---|
| Title | RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin |
| Official title | Multicentric, Controlled and Randomised Open Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin Using Pharmacologic Measures of Ribavirin Exposition During Combination Peginterferon Alfa-2 and Ribavirin Treatment in Naive Patients With Chronic Hepatitis C of… |
| Acronym | RIBAJUSTE |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis C |
| Intervention type | Drug |
| Interventions | Peg-interferon alpha 2a and ribavin, ribavirin with adaptation dose |
| Enrollment | 236 |
| Start date | Apr 1, 2006 |
| Primary completion | Mar 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | Jun 12, 2007 |
| Last update posted | Jan 9, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: